Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Big Lots

Kroger

Stocks are trading below Peter Lynch value and have good business predictability.

3 Defensive Retail Companies to Consider as US Producer Prices Decline

FedEx

FedEx Corp. (NYSE: FDX) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) made a huge announcement on Tuesday that will make it easier for customers to drop off returns at thousands of Walgreens across the United States.

Meet the New FedEx and Walgreens Partnership Ahead of the Holidays

FedEx Corp. FDX, -1.61% announced Tuesday a partnership with Walgreens Boots Alliance Inc.

FedEx partners with Walgreens, to allow package returns at Walgreens stores

This collaboration is in line with Walgreens' (WBA) commitment toward providing affordable and convenient healthcare facilities to residents of North Carolina.

Walgreens Inks Retail Health Collaboration Deal With Novant

Walgreens Boots Alliance said it will stop sales of e-cigarettes at all of its U.S. drugstores as regulatory scrutiny of vaping intensifies.

Walgreens To Stop Sales Of E-Cigarettes As Scrutiny Of Vaping Intensifies

Bank of America

Booz Allen Hamilton Hld

Cigna

CVS Health

Chevron

CoreCivic

GEO Group

Alphabet

Gap Inc

Lockheed Martin

Northrop Grumman

Papa John's

Wells Fargo

Exxon Mobil

J.P. Morgan's list includes U.S. companies that would be affected by policy initiatives in areas like anti-trust, financial regulation, climate change, healthcare reform and minimum wage, among others.

These stocks could have the most to lose if a progressive Democratic agenda takes hold in 2020

Delta Air Lines

Levi Strauss

Domino's Pizza

Fastenal

Infosys

The markets are in the quiet period before the third-quarter earnings reporting season, but a few prominent companies will be sharing their results this week.

Delta Air Lines, Levi Strauss, Walgreens and More Earnings Coming This Week

Walgreens Boots Alliance Inc. WBA, -1.10% said Wednesday it was collaborating with Postmates for on-demand delivery of over-the-counter medications and wellness, beauty and grocery products in New York City.

Walgreens, Postmates team up on deliveries in New York City

Walgreens Boots Alliance (WBA) closed the most recent trading day at $54.70, moving -1.1% from the previous trading session.

Walgreens Boots Alliance (WBA) Stock Moves -1.1%: What You Should Know

Walgreens Boots Alliance stock just ran up to a historically bearish trendline

Don't Bet On A Breakout From This Dow Underperformer

Walgreens (WBA) announced today that they would be suspending the sales of Sanofi's (SNY) heartburn medication Zantac.

Walgreens (WBA) Becomes Latest Retailer to Suspend Zantac Sales

Walgreens is the latest retailer to suspend sales of Sanofi's heartburn medication Zantac and other generic ranitidine products while the U.S. Food and Drug Administration reviews their safety.

Walgreens joins CVS in suspending sales of heartburn medicine Zantac during safety review

Caterpillar

Johnson & Johnson

Pfizer

With just over one quarter left in 2019, it has been another banner year for stock market investors, with double-digit gains in all three major averages.

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

ConocoPhillips

Eli Lilly

These blue chips are perfectly positioned to gain ground through the fourth quarter and into 2020.

3 Stocks to Buy in the Fourth Quarter

Which stock wins in a battle between these pharmacy giants?

Better Buy: Walgreens Boots Alliance vs. CVS Health

Walgreens (WBA) drone delivery is coming to Virginia in October as part of a test run for customers living in Christiansburg.
The post Walgreens Drone Delivery Tests to Begin Next Month appeared first on InvestorPlace.

Walgreens Drone Delivery Tests to Begin Next Month

Walgreens Boots Alliance Inc. WBA, +0.66% said Thursday that it has partnered with Wing Aviation LLC, an Alphabet Inc.

Walgreens testing drone delivery with Alphabet company, Wing

Wing, the drone delivery company that started its life within the Google X lab before spinning out into its own thing under the Alphabet umbrella, is prepping for takeoff. The company announced this morning that it’s launching a test program in Virginia with Walgreens, FedEx, and local retailer Sugar Magnolia.

Wing will test drone delivery in the US with Walgreens and FedEx

The pilot program will deliver food and beverage, over-the-counter medications and other items within minutes, the company said. Prescription deliveries will not be available.

Walgreens to test drone delivery service with FedEx and Alphabet's Wing

CORRECTION: Walgreens to test drone delivery service with Alphabet's Wing

Walgreens Boots Alliance stock has carved a double bottom after posting the most extreme oversold readings since the 1970s.

Walgreens Stock Could Reward Bottom Fishers

Walgreens' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also gaining traction from a solid retail prescription market.

Walgreens' Retail Pharmacy Stays Firm Amid Reimbursement Woes

Apple

Walgreens Boots Alliance Inc. WBA, +2.07% said Thursday customers who use Apple Inc.

Walgreens to give customers using Apple's Apple Card 3% cash back on purchases

Apple Card’s rewards program, Daily Cash, is expanding today with the addition of Walgreens. The retailer joins Uber and Uber Eats to become the latest merchant to offer 3% Daily Cash to Apple Card customers who use Apple Pay at checkout.

Walgreens joins Apple Card’s rewards program to offer 3% Daily Cash on purchases

AbbVie

Federal Realty Investment Trust

Altria

Investor concerns about a potential recession and bear market are at the highest levels in a decade. The media is constantly hyping the idea that a recession is imminent.

News for Walgreens Stock (WBA)